5,N,N-TMT
From Wikipedia, the free encyclopedia
5,N,N-TMT
|
|
Systematic (IUPAC) name | |
(2-(5-methyl-1H-indol-3-yl)-1-methyl-ethyl)dimethylamine | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C13H18N2 |
Mol. mass | 202.30 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
5,N,N-trimethyltryptamine (5,N,N-TMT; 5-TMT) is a tryptamine derivative that is a hallucinogenic drug. It was first made in 1958 by E. H. Young. [1] In animal experiments it was found to be in between DMT and 5-MeO-DMT in potency [2] [3] which would suggest an active dosage for humans in the 20-60mg range. Human psychoactivity for this compound has been claimed in reports on websites such as Erowid but has not been independently confirmed.
[edit] References
- ^ Young EH, J. Chem. Soc. 3493 (1958)
- ^ Glennon et al, J. Med. Chem. 22:428-432 (1979)
- ^ Glennon RA, Young R, Rosecrans JA, Kallman MJ. Hallucinogenic agents as discriminative stimuli: A correlation with serotonin receptor affinities.Psychopharmacology (Berlin). 1980 May, 68(2): 155-158
|